Labcorp Holdings LH Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Biopharma Laboratory Services | $3.16B+7.7% | $3.1B+6.0% | $3.07B+7.8% | $3.01B+7.3% | $2.93B+5.1% | |
| Diagnostics | $11.01B+6.9% | $10.88B+7.2% | $10.73B+8.4% | $10.52B+8.5% | $10.29B+8.2% | |
| Operating Income by Business | ||||||
| Biopharma Laboratory Services | $512.3M+10.0% | $498.5M+8.6% | $493.1M+15.4% | $481.8M+18.8% | $465.9M+17.3% | |
| Corporate Segment | -$466.4M+30.8% | -$482.2M+28.1% | -$570.6M+13.0% | -$633.2M+3.1% | -$674.3M-3.6% | |
| Diagnostics | $1.81B+12.1% | $1.78B+10.8% | $1.72B+7.5% | $1.66B+3.6% | $1.62B+3.1% | |
| Other Cost and Expense, Operating by Business | ||||||
| Biopharma Laboratory Services | $384.5M+6.6% | $384.8M+4.5% | $388.4M+4.9% | $374.6M-0.8% | $360.6M-6.9% | |
| Diagnostics | $1.8B+7.4% | $1.79B+10.0% | $1.77B— | $1.73B— | $1.68B— | |
| Accounts Receivable, before Allowance for Credit Loss by Business | ||||||
| Biopharma Laboratory Services | $3.1B— | $3.05B— | $2.99B— | —— | —— | |
| Diagnostics | $5.67B+6.7% | $5.56B+7.5% | $5.47B+8.3% | $5.4B+10.4% | $5.32B+13.9% | |
| Labor and Related Expense by Business | ||||||
| Biopharma Laboratory Services | $1.24B+6.6% | $1.22B+4.8% | $1.2B+5.2% | $1.18B+5.2% | $1.16B+4.8% | |
| Diagnostics | $4.75B+5.4% | $4.69B+5.6% | $4.64B+8.0% | $4.59B+9.9% | $4.51B+9.2% | |
| Supplies Expense by Business | ||||||
| Biopharma Laboratory Services | $488.9M+8.8% | $478.5M+8.3% | $483.6M+11.8% | $473.6M+8.5% | $449.5M+1.5% | |
| Diagnostics | $2.38B+6.6% | $2.36B+6.7% | $2.33B+8.1% | $2.28B+6.8% | $2.24B+6.0% | |
| Goodwill by Business | ||||||
| Biopharma Laboratory Services | $5.44B— | —— | —— | —— | —— | |
| Diagnostics | $21.54B— | —— | —— | —— | —— | |
| Depreciation by Business | ||||||
| Biopharma Laboratory Services | $116M-3.3% | $116M-5.4% | $116.2M-4.1% | $118.7M+0.8% | $120M+3.8% | |
| Diagnostics | $260.9M+0.7% | $258.8M-0.1% | $262.6M+5.5% | $261.3M+7.6% | $259M+8.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Labcorp Holdings break its business down?
- Labcorp Holdings (LH) reports revenue by business across 2 parts — Biopharma Laboratory Services and Diagnostics. Each is extracted from the segment footnotes and tracked over time.
- Where does Labcorp Holdings's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Labcorp Holdings's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
